A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis

The purpose of this pilot study was to explore the efficacy, safety, and tolerability of vidofludimus calcium (VC) in the treatment of primary sclerosing cholangitis (PSC). This was a single‐arm open‐label pilot study with a cohort of 18 patients with PSC. Study patients received VC for a period of...

Descripción completa

Detalles Bibliográficos
Autores principales: Carey, Elizabeth J., Eaton, John, Clayton, Mitchell, Gossard, Andrea, Iqbal, Sara, Ullah, Hamid, Zhang, Nan, Butterfield, Richard, Lindor, Keith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234677/
https://www.ncbi.nlm.nih.gov/pubmed/35238498
http://dx.doi.org/10.1002/hep4.1926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234677/
https://www.ncbi.nlm.nih.gov/pubmed/35238498
http://dx.doi.org/10.1002/hep4.1926

Ejemplares similares